Christiane Gino Colu Nery, Maria Arlete da Silva Pires, G. A. Pianetti, Cristina Duarte Vianna-Soares
{"title":"降糖药格列本脲的特性","authors":"Christiane Gino Colu Nery, Maria Arlete da Silva Pires, G. A. Pianetti, Cristina Duarte Vianna-Soares","doi":"10.1590/S1516-93322008000100008","DOIUrl":null,"url":null,"abstract":"Glibenclamide (GLIB) or glyburide, a second-generation hypoglycemic agent is orally used in the form of tablets for the treatment of diabetes mellitus. Bulk GLIB has a low aqueous solubility and it may yield low drug release in the dissolution test, causing variabilility in the treatment. This work evaluates the bulk GLIB features, which may influence drug release profile, hence, bioavailability, by means of techniques such as nitrogen sorption analysis, laser diffraction, thermal analysis, IV/UV spectroscopy and X-ray analysis.","PeriodicalId":21193,"journal":{"name":"Revista Brasileira De Ciencias Farmaceuticas","volume":"10 1","pages":"61-73"},"PeriodicalIF":0.0000,"publicationDate":"2008-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"13","resultStr":"{\"title\":\"Caracterização do fármaco hipoglicemiante glibenclamida\",\"authors\":\"Christiane Gino Colu Nery, Maria Arlete da Silva Pires, G. A. Pianetti, Cristina Duarte Vianna-Soares\",\"doi\":\"10.1590/S1516-93322008000100008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Glibenclamide (GLIB) or glyburide, a second-generation hypoglycemic agent is orally used in the form of tablets for the treatment of diabetes mellitus. Bulk GLIB has a low aqueous solubility and it may yield low drug release in the dissolution test, causing variabilility in the treatment. This work evaluates the bulk GLIB features, which may influence drug release profile, hence, bioavailability, by means of techniques such as nitrogen sorption analysis, laser diffraction, thermal analysis, IV/UV spectroscopy and X-ray analysis.\",\"PeriodicalId\":21193,\"journal\":{\"name\":\"Revista Brasileira De Ciencias Farmaceuticas\",\"volume\":\"10 1\",\"pages\":\"61-73\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"13\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Brasileira De Ciencias Farmaceuticas\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1590/S1516-93322008000100008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Brasileira De Ciencias Farmaceuticas","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1590/S1516-93322008000100008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Caracterização do fármaco hipoglicemiante glibenclamida
Glibenclamide (GLIB) or glyburide, a second-generation hypoglycemic agent is orally used in the form of tablets for the treatment of diabetes mellitus. Bulk GLIB has a low aqueous solubility and it may yield low drug release in the dissolution test, causing variabilility in the treatment. This work evaluates the bulk GLIB features, which may influence drug release profile, hence, bioavailability, by means of techniques such as nitrogen sorption analysis, laser diffraction, thermal analysis, IV/UV spectroscopy and X-ray analysis.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
